A symposium focused on comorbidities in aging cats
Virbac brought together nearly 100 feline medicine specialists from Europe, the United States and Australia in Edinburgh around the management of elderly cats.
According to the press release, the stated objective is to coordinate prevention, care and nutrition in the face of increasing feline life expectancy and the frequency of comorbidities (kidney disease, hyperthyroidism, joint disorders).
The group highlights early detection and systemic management of age-related pathologies as the focus of this meeting. In his opening remarks, Paul Martingell, CEO of Virbac, stated: "Reaching an advanced age is a milestone, not a surrender of quality of life. Our commitment is to stand alongside veterinarians and pet owners to ensure that every senior cat receives specialized, attentive and cutting-edge care, preserving its vitality and comfort to the end."
Five areas of action presented to practitioners
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
During the day, five international speakers presented their work around five areas of action identified by the group: early diagnosis, endocrinology, renal care and nutrition, mobility and prevention.
Virbac indicates its desire to detect earlier, break down silos in treatments for better management of comorbidities and eliminate stress related to care.
The press release recalls field data cited to support this direction: 90% of cats over 12 years old would suffer from osteoarthritis, one third would be affected by chronic kidney disease, up to 10% of cats over 9 years old would develop hyperthyroidism, and 40% of owners would encounter difficulties administering treatment to their animal.
SectorPharmacie et biotechnologies›Vaccins et laboratoires de recherche
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 768 millions d'euros
Quarterly revenue: 768 millions d'euros
EBITDA: 161,4 millions d'euros
Net income: 87,4 millions d'euros
195,9 millions d'euros
Guidance from the release
« Objectifs 2026 confirmés, dans la borne haute de la fourchette »
Outlook / guidance
Expected revenue: 1 575 millions d'euros
Management commentary: « Bien que nos objectifs pour l'ensemble de l'année 2026 restent inchangés, notre forte dynamique du premier semestre (+7,4 % de croissance) nous permet de viser la borne haute de notre fourchette de croissance du chiffre d'affaires, comprise entre 5,5 % et 7,5 % à PCC »
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.